Characterization of FGFR signaling in prostate cancer stem cells and inhibition via TKI treatment
J. Ko, A. N. Meyer, M. Haas, D. J. Donoghue
This study shows FGFR1 is critical for prostate cancer stem cell proliferation and that FGFR inhibitors may be effective for AR-independent CRPC.
bioRxiv · Dec 13, 2020 · PreprintCancer Biology